A review on therapeutical potential of paeonol in atherosclerosis

W Yu, I Ilyas, N Aktar, S Xu - Frontiers in Pharmacology, 2022 - frontiersin.org
The morbidity and mortality of atherosclerotic cardiovascular disease (ASCVD) is increasing
year by year. Cortex Moutan is a traditional Chinese medicinal herb that has been widely …

The RAAS axis and SARS-CoV-2: from oral to systemic manifestations

MA Maranduca, CG Vamesu, DM Tanase, A Clim… - Medicina, 2022 - mdpi.com
One of the essential regulators of arterial blood pressure, the renin-angiotensin-aldosterone
system (RAAS) seems to be one of the most complex mechanisms in the human body. Since …

Remdesivir-induced bradycardia is not associated with worse outcome in patients with COVID-19: a retrospective analysis

I Pantazopoulos, G Mavrovounis, G Dimeas… - American Journal of …, 2022 - Springer
Background COVID-19, is primarily a respiratory illness but is known to cause
extrapulmonary manifestations, especially on the cardiovascular system. Bradycardia is …

High AST/ALT Ratio Is Associated with Cardiac Involvement in Acute COVID-19 Patients

M Karatas, N Keles, KE Parsova, HO Ciftci, S Ozkok… - Medicina, 2023 - mdpi.com
Background and Objectives: We aimed to assess the effect of AST/ALT ratio on
echocardiographic and cardiac magnetic resonance imaging (CMRI) parameters after …

Risk and protective factors for Long COVID in Brazilian adults (CUME Study)

J Eduvirgem, J Bressan, HHM Hermsdorff… - Frontiers in …, 2024 - frontiersin.org
Background Most people recover from COVID-19, however, between 5 to 20% have
experienced new, recurring, or continuous health problems four or more weeks after being …

Impact of the COVID-19 pandemic on initiation of antihypertensive drugs in Sweden: an interrupted time series study

A Tomas, B Wettermark, F Nyberg, M Hajiebrahimi - BMJ open, 2024 - bmjopen.bmj.com
Objectives Antihypertensives reduce the risk of myocardial infarction and stroke. Restrictions
during the COVID-19 pandemic limited access to healthcare, which may have had a …

[HTML][HTML] Laboratory medicine in pandemic of COVID-19

L Tandara, P Filipi, D Supe Domic, B Kresic, I Ivcic… - Biochemia …, 2022 - hrcak.srce.hr
Sažetak After the outbreak in China in the year 2019, severe acute respiratory syndrome
Coronavirus 2 (SARS-CoV-2) quickly spread around the world causing a protracted …

Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing

H Bai, J Ma, W Mao, X Zhang, Y Nie, J Hao… - Blood Cells, Molecules …, 2022 - Elsevier
The T cell-mediated immune responses associated with asymptomatic infection (AS) of
SARS-CoV-2 remain largely unknown. The diversity of T-cell receptor (TCR) repertoire is …

Mallampati score is an independent predictor of active oxygen therapy in patients with COVID-19

M Dyrbuś, A Oraczewska, S Szmigiel… - Journal of Clinical …, 2022 - mdpi.com
Mallampati score has been identified and accepted worldwide as an independent predictor
of difficult intubation and obstructive sleep apnea. We aimed to determine whether …

Phenotype clustering of hospitalized high-risk patients with COVID-19—a machine learning approach within the multicentre, multinational PCHF-COVICAV registry

M Sokolski, S Trenson, K Reszka, S Urban… - Cardiology …, 2024 - journals.viamedica.pl
Imtroduction: The high-risk population of patients with cardiovascular (CV) disease or risk
factors (RF) suffering from COVID-19 is heterogeneous. Several predictors for impaired …